A carregar...

Enabling and disabling Polo-like kinase 1 inhibition through chemical genetics

Polo-like kinase 1 (Plk1) is a core regulator of cell division and an emerging target for cancer therapy. Pharmacologic inhibitors of Plk1 exist but affect other kinases complicating their in vivo validation. To address this, we examined effects of two structurally unrelated Plk1 inhibitors (BI-2536...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Burkard, Mark E., Santamaria, Anna, Jallepalli, Prasad V.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3376236/
https://ncbi.nlm.nih.gov/pubmed/22422077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cb200551p
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!